The present invention is based on the finding that activation of PPAR.gamma. plays a key role in inducing growth arrest and differentiation of certain actively proliferating cells. We show that administration of PPAR.gamma. agonists, such as thiazolidinedione ligands (TZDs), is effective both in vitro and in vivo at inhibiting the proiferation of such cells.

La présente invention est basée sur la constatation que l'activation de PPAR.gamma. joue un rôle principal en induisant l'arrestation de croissance et la différentiation de certaines cellules activement de prolifération. Nous prouvons que l'administration des agonistes de PPAR.gamma., tels que des ligands de thiazolidinedione (TZDs), est efficace tous les deux in vitro et in vivo à empêcher le proiferation de telles cellules.

 
Web www.patentalert.com

< Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics

< Human blue-light photoreceptor hCRY2

> Process for the preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and -benzylidenyl compounds

> N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof

~ 00068